ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2019

Jan 31, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2019-01-28

Reporting Person: Schwartz Jonathan David (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-28	Stock Option (Right to Buy)	$14.56	A	75000	Acquired	2029-01-28	Common Stock (75000)	Direct

Footnotes

F1: This option represents a right to purchase a total of 75,000 shares of the Issuer's Common Stock, 25,000 of which will become fully vested and exercisable on January 28, 2020, with the remaining 50,000 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.